Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding-Reference-Cited by-同舟云学术

Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding

Published:2012-02-20 Issue:8 Volume:26 Page:1829-1841
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ptasinska A,Assi S A,Mannari D,James S R,Williamson D,Dunne J,Hoogenkamp M,Wu M,Care M,McNeill H,Cauchy P,Cullen M,Tooze R M,Tenen D G,Young B D,Cockerill P N,Westhead D R,Heidenreich O,Bonifer C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201249.pdf

Reference60 articles.

1. Bonifer C, Bowen DT . Epigenetic mechanisms regulating normal and malignant haematopoiesis: new therapeutic targets for clinical medicine. Expert Rev Mol Med 2010; 12: e6.

2. Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 1996; 87: 697–708.

3. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR . AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321–330.

4. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992; 80: 1825–1831.

5. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993; 12: 2715–2721.

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Cell Chromatin Accessibility Analysis Reveals the Epigenetic Basis and Signature Transcription Factors for the Molecular Subtypes of Colorectal Cancers;Cancer Discovery;2024-03-05

2. Nucleic acid therapeutics as differentiation agents for myeloid leukemias;Leukemia;2024-02-29

3. Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth;Nature Communications;2024-02-14

4. Epigenetic alterations in AML: Deregulated functions leading to new therapeutic options;International Review of Cell and Molecular Biology;2024

5. Mechanisms for the development of therapy-related leukaemia caused by topoisomerase inhibitors;Биохимия;2023-12-15